Wuhan Mingde Biomedical Technology Co., Ltd. intends to acquire 100% equity of Wuhan Bicare Rescue Products Co., Ltd. from Blue Sail Medical Co., Ltd. for a total cash consideration of 190 million RMB. This transaction constitutes a major asset purchase aimed at expanding the company's business scope. The report outlines the transaction terms, definitions, and professional terminology relevant to the acquisition.
Summary generated by AI · Always verify with source document
Stock Code: 002932 Stock Abbreviation: *ST Mingde Listing Venue: Shenzhen Stock Exchange
[Image: Company Logo]
Wuhan Mingde Biomedical Technology Co., Ltd.
Summary of the Major Asset Purchase Report
| Project | Name of Counterparty |
|---|---|
| Counterparty for Asset Purchase | Blue Sail Medical Co., Ltd. |
Independent Financial Advisor
August 2026
Definitions
In this summary, unless the context otherwise requires, the following abbreviations have the following meanings:
I. General Terms
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.